Author
Listed:
- Luis M. Tuesta
(Howard Hughes Medical Institute
Boston Children’s Hospital
Harvard Medical School)
- Mohamed N. Djekidel
(Howard Hughes Medical Institute
Boston Children’s Hospital
Harvard Medical School)
- Renchao Chen
(Howard Hughes Medical Institute
Boston Children’s Hospital
Harvard Medical School)
- Falong Lu
(Howard Hughes Medical Institute
Boston Children’s Hospital
Harvard Medical School)
- Wengang Wang
(Howard Hughes Medical Institute
Harvard Medical School)
- Bernardo L. Sabatini
(Howard Hughes Medical Institute
Harvard Medical School)
- Yi Zhang
(Howard Hughes Medical Institute
Boston Children’s Hospital
Harvard Medical School
Boston Children’s Hospital)
Abstract
Midbrain dopamine (mDA) neurons play a central role in reward signaling and are widely implicated in psychiatric and neurodegenerative disorders. To understand how mDA neurons perform these functions, it is important to understand how mDA-specific genes are regulated. However, cellular heterogeneity in the mammalian brain presents a major challenge to obtaining this understanding. To this end, we developed a virus-based approach to label and capture mDA nuclei for transcriptome (RNA-Seq), and low-input chromatin accessibility (liDNase-Seq) profiling, followed by predictive modeling to identify putative transcriptional regulators of mDA neurons. Using this method, we identified Gmeb1, a transcription factor predicted to regulate expression of Th and Dat, genes critical for dopamine synthesis and reuptake, respectively. Gmeb1 knockdown in mDA neurons resulted in downregulation of Th and Dat, as well as in severe motor deficits. This study thus identifies Gmeb1 as a master regulator of mDA gene expression and function, and provides a general method for identifying cell type-specific transcriptional regulators.
Suggested Citation
Luis M. Tuesta & Mohamed N. Djekidel & Renchao Chen & Falong Lu & Wengang Wang & Bernardo L. Sabatini & Yi Zhang, 2019.
"In vivo nuclear capture and molecular profiling identifies Gmeb1 as a transcriptional regulator essential for dopamine neuron function,"
Nature Communications, Nature, vol. 10(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10267-0
DOI: 10.1038/s41467-019-10267-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10267-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.